Advances in Biomarkers for Muscular Dystrophies: a Comprehensive Review.
BACKGROUND Muscular dystrophies (MDs) are a group of genetically heterogeneous diseases characterized by progressive muscle degeneration and functional impairment. Current treatment options remain limited, highlighting the urgent need for biomarkers to enhance diagnosis, monitor disease progression, and evaluate treatm...